Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Aleman

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Alimentary Pharmacology & Therapeutics|January 12, 2024
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infectionLisa Sandmann, Elisabetta Degasperi, Kerstin Port, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2021
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functionsKatie Healy, Andrea Pavesi, Tiphaine Parrot, et al.
Scandinavian Journal of Gastroenterology|May 2, 2020
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorderMartin Kåberg, Simon B Larsson, Anna Jerkeman, et al.
Infectious Diseases (London, England)|October 16, 2019
Management of hepatitis B virus infection, updated Swedish guidelinesJohan Westin, Soo Aleman, Maria Castedal, et al.
Scandinavian Journal of Gastroenterology|August 20, 2019
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and NorwayMidori Kjellin, Hege Kileng, Dario Akaberi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2024
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patientsHannes Hegmar, Axel Wester, Soo Aleman, et al.
Hepatology (Baltimore, Md.)|May 12, 2026
Diabetes, male sex, low levels of HBsAg, HDV RNA and ALT predict spontaneous HDV suppression in chronic hepatitis DHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
The Journal of Infectious Diseases|December 2, 2025
Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis BMahin Ghorbani, Agne Kvedaraite, Khaled Al-Manei, et al.
European Journal of Immunology|October 30, 2018
Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17Michał J Sobkowiak, Haleh Davanian, Robert Heymann, et al.
Haematologica|January 20, 2022
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trialLisa Blixt, David Wullimann, Soo Aleman, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|January 12, 2024
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infectionLisa Sandmann, Elisabetta Degasperi, Kerstin Port, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2021
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functionsKatie Healy, Andrea Pavesi, Tiphaine Parrot, et al.
Scandinavian Journal of Gastroenterology|May 2, 2020
High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorderMartin Kåberg, Simon B Larsson, Anna Jerkeman, et al.
Infectious Diseases (London, England)|October 16, 2019
Management of hepatitis B virus infection, updated Swedish guidelinesJohan Westin, Soo Aleman, Maria Castedal, et al.
Scandinavian Journal of Gastroenterology|August 20, 2019
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and NorwayMidori Kjellin, Hege Kileng, Dario Akaberi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2024
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patientsHannes Hegmar, Axel Wester, Soo Aleman, et al.
Hepatology (Baltimore, Md.)|May 12, 2026
Diabetes, male sex, low levels of HBsAg, HDV RNA and ALT predict spontaneous HDV suppression in chronic hepatitis DHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
The Journal of Infectious Diseases|December 2, 2025
Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis BMahin Ghorbani, Agne Kvedaraite, Khaled Al-Manei, et al.
European Journal of Immunology|October 30, 2018
Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17Michał J Sobkowiak, Haleh Davanian, Robert Heymann, et al.
Haematologica|January 20, 2022
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trialLisa Blixt, David Wullimann, Soo Aleman, et al.
Pageof 15